• Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A., Ronneberger, O., Willmore, L., Ballard, A.J., Bambrick, J., et al., 2024. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 630, 493-500.

  • Akinci, E., Bodur, H.,Leblebicioglu, H., 2013. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis, 13, 429-437.

  • Akinci, E., Bodur, H., Sunbul, M.,Leblebicioglu, H., 2016. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever. Antiviral Res, 132, 233-243.

  • Aligholipour Farzani, T., Foldes, K., Hanifehnezhad, A., Yener Ilce, B., Bilge Dagalp, S., Amirzadeh Khiabani, N., Ergunay, K., Alkan, F., Karaoglu, T., Bodur, H.,Ozkul, A., 2019. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNalpha/beta/gammaR-/- Mice Models. Viruses, 11, 237.

  • Aslam, M., Abbas, R.Z.,Alsayeqh, A., 2023. Distribution pattern of Crimean-Congo Hemorrhagic Fever in Asia and the Middle East. Front Public Health, 11, 1093817.

  • Bailey, C.C., Kondur, H.R., Huang, I.C.,Farzan, M., 2013. Interferon-induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem, 288, 32184-32193.

  • Bailey, C.C., Zhong, G., Huang, I.C.,Farzan, M., 2014. IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. Annu Rev Virol, 1, 261-283.

  • Bente, D.A., Forrester, N.L., Watts, D.M., Mcauley, A.J., Whitehouse, C.A.,Bray, M., 2013. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res, 100, 159-189.

  • Bodur, H., Akinci, E., Ascioglu, S., Onguru, P.,Uyar, Y., 2012. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis, 18, 640-642.

  • Bote, J., Corkrey, H.A.,Koupenova, M., 2022. Human Platelets and Influenza Virus: Internalization and Platelet Activation. Platelets, 33, 184-191.

  • Brass, A.L., Huang, I.C., Benita, Y., John, S.P., Krishnan, M.N., Feeley, E.M., Ryan, B.J., Weyer, J.L., Van Der Weyden, L., Fikrig, E., Adams, D.J., Xavier, R.J., Farzan, M.,Elledge, S.J., 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell, 139, 1243-1254.

  • Campbell, R.A., Schwertz, H., Hottz, E.D., Rowley, J.W., Manne, B.K., Washington, A.V., Hunter-Mellado, R., Tolley, N.D., Christensen, M., Eustes, A.S., et al., 2019. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood, 133, 2013-2026.

  • Chang, M., Min, Y.Q., Xu, Z., Deng, F., Wang, H.,Ning, Y.J., 2024. Host factor MxA restricts Dabie bandavirus infection by targeting the viral NP protein to inhibit NP-RdRp interaction and ribonucleoprotein activity. J Virol, 98, e0156823.

  • Chen, H., Jie, C., Tang, L.P., Meng, H., Li, X.B., Li, Y.B., Chen, L.X., Yan, C., Kurihara, H., Li, Y.F.,He, R.R., 2017. New insights into the effects and mechanism of a classic traditional Chinese medicinal formula on influenza prevention. Phytomedicine, 27, 52-62.

  • Chumakov, M.P., Butenko, A.M., Shalunova, N.V., Mart'ianova, L.I., Smirnova, S.E., Bashkirtsev Iu, N., Zavodova, T.I., Rubin, S.G., Tkachenko, E.A., Karmysheva, V., Reingol'd, V.N., Popov, G.V.,Savinov, A.P., 1968. [New data on the viral agent of Crimean hemorrhagic fever]. Vopr Virusol, 13, 377.

  • Compton, A.A., Roy, N., Porrot, F., Billet, A., Casartelli, N., Yount, J.S., Liang, C.,Schwartz, O., 2016. Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. EMBO Rep, 17, 1657-1671.

  • Cross, R.W., Prasad, A.N., Borisevich, V., Geisbert, J.B., Agans, K.N., Deer, D.J., Fenton, K.A.,Geisbert, T.W., 2020. Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys. PLoS Negl Trop Dis, 14, e0008637.

  • Dai, S., Wu, Q., Wu, X., Peng, C., Liu, J., Tang, S., Zhang, T., Deng, F.,Shen, S., 2021. Differential Cell Line Susceptibility to Crimean-Congo Hemorrhagic Fever Virus. Front Cell Infect Microbiol, 11, 648077.

  • Denz, P.J., Speaks, S., Kenney, A.D., Eddy, A.C., Papa, J.L., Roettger, J., Scace, S.C., Rubrum, A., Hemann, E.A., Forero, A., Webby, R.J., Bowman, A.S.,Yount, J.S., 2024. Innate immune control of influenza virus interspecies adaptation via IFITM3. Nat Commun, 15, 9375.

  • Deyde, V.M., Khristova, M.L., Rollin, P.E., Ksiazek, T.G.,Nichol, S.T., 2006. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol, 80, 8834-8842.

  • Dib, P.R.B., Quirino-Teixeira, A.C., Merij, L.B., Pinheiro, M.B.M., Rozini, S.V., Andrade, F.B.,Hottz, E.D., 2020. Innate immune receptors in platelets and platelet-leukocyte interactions. J Leukoc Biol, 108, 1157-1182.

  • Du, S., Wang, Y., Wang, J., Ma, Y., Xu, W., Shi, X., Li, L., Hao, P., Liu, Q., Liao, M., Zhou, B., Jin, N., Wong, Y.K., Hu, L., Wang, J., Liu, W.,Li, C., 2024. IFITM3 inhibits severe fever with thrombocytopenia syndrome virus entry and interacts with viral Gc protein. J Med Virol, 96, e29491.

  • Ergonul, O., 2012. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol, 2, 215-220.

  • Fang, Y., Shen, S., Zhang, J., Xu, L., Wang, T., Fan, L., Zhu, Q., Xiao, J., Wu, X., Jin, J., Wu, Q., Zhang, Y., Tang, S., Zheng, X.,Deng, F., 2024. Thrombocytopenia in SFTS due to platelets with altered function undergoing cell death pathways. J Infect Dis, 231, e183-e194.

  • Fereidouni, M., Apanaskevich, D. A., Pecor, D. B., Pshenichnaya, N. Y., Abuova, G. N., Tishkova, F. H., Bumburidi, Y., Zeng, X., Kuhn, J. H., Keshtkar-Jahromi, M., 2023. Crimean-Congo hemorrhagic fever virus in Central, Eastern, and South-eastern Asia. Virol. Sin. 38, 171-183.

  • Garrison, A.R., Smith, D.R.,Golden, J.W., 2019. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease. Viruses, 11.

  • Guo, R., Shen, S., Zhang, Y., Shi, J., Su, Z., Liu, D., Liu, J., Yang, J., Wang, Q., Hu, Z., Zhang, Y.,Deng, F., 2017. A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China. Virol Sin, 32, 80-88.

  • Haddock, E., Feldmann, F., Hawman, D.W., Zivcec, M., Hanley, P.W., Saturday, G., Scott, D.P., Thomas, T., Korva, M., Avsic-Zupanc, T., Safronetz, D.,Feldmann, H., 2018. A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. Nat Microbiol, 3, 556-562.

  • Hoogstraal, H., 1979. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol, 15, 307-417.

  • Jia, R., Pan, Q., Ding, S., Rong, L., Liu, S.L., Geng, Y., Qiao, W.,Liang, C., 2012. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol, 86, 13697-13707.

  • Klein, S., Golani, G., Lolicato, F., Lahr, C., Beyer, D., Herrmann, A., Wachsmuth-Melm, M., Reddmann, N., Brecht, R., Hosseinzadeh, M., Kolovou, A., Makroczyova, J., Peterl, S., Schorb, M., Schwab, Y., Brugger, B., Nickel, W., Schwarz, U.S.,Chlanda, P., 2023. IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion. Cell Host Microbe, 31, 616-633 e620.

  • Koupenova, M., Livada, A.C.,Morrell, C.N., 2022. Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity. Circ Res, 130, 288-308.

  • Krissinel, E.,Henrick, K., 2007. Inference of macromolecular assemblies from crystalline state. J Mol Biol, 372, 774-797.

  • Li, Y., Zhang, J., Liu, X., Zhang, X.,Shi, G., 2025. Identification of IFITM3 as a diagnostic biomarker of systemic lupus erythematosus and its association with disease activity based on multi-omics and experimental verification. Lupus, 34, 57-70.

  • Lin, X., Yu, S., Ren, P., Sun, X.,Jin, M., 2020. Human microRNA-30 inhibits influenza virus infection by suppressing the expression of SOCS1, SOCS3, and NEDD4. Cell Microbiol, 22, e13150.

  • Lindquist, M.E., Zeng, X., Altamura, L.A., Daye, S.P., Delp, K.L., Blancett, C., Coffin, K.M., Koehler, J.W., Coyne, S., Shoemaker, C.J., Garrison, A.R.,Golden, J.W., 2018. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice. J Virol, 92.

  • Liu, J., Xu, M., Tang, B., Hu, L., Deng, F., Wang, H., Pang, D.W., Hu, Z., Wang, M.,Zhou, Y., 2019. Single-Particle Tracking Reveals the Sequential Entry Process of the Bunyavirus Severe Fever with Thrombocytopenia Syndrome Virus. Small, 15, e1803788.

  • Lu, J., Pan, Q., Rong, L., He, W., Liu, S.L.,Liang, C., 2011. The IFITM proteins inhibit HIV-1 infection. J Virol, 85, 2126-2137.

  • Machlus, K.R.,Italiano, J.E., Jr., 2013. The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol, 201, 785-796.

  • Marziali, F., Delpeuch, M., Kumar, A., Appourchaux, R., Dufloo, J., Tartour, K., Etienne, L.,Cimarelli, A., 2021. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1. J Virol, 95, e0043921.

  • Mcentire, C.R.S., Song, K.W., Mcinnis, R.P., Rhee, J.Y., Young, M., Williams, E., Wibecan, L.L., Nolan, N., Nagy, A.M., Gluckstein, J., Mukerji, S.S.,Mateen, F.J., 2021. Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases. Front Neurol, 12, 634827.

  • Mo, Q., Feng, K., Dai, S., Wu, Q., Zhang, Z., Ali, A., Deng, F., Wang, H., Ning, Y. J., 2023. Transcriptome profiling highlights regulated biological processes and type III interferon antiviral responses upon Crimean-Congo hemorrhagic fever virus infection. Virol. Sin. 38, 34-46.

  • Narayana, S.K., Helbig, K.J., Mccartney, E.M., Eyre, N.S., Bull, R.A., Eltahla, A., Lloyd, A.R.,Beard, M.R., 2015. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry. J Biol Chem, 290, 25946-25959.

  • Neogi, U., Elaldi, N., Appelberg, S., Ambikan, A., Kennedy, E., Dowall, S., Bagci, B.K., Gupta, S., Rodriguez, J.E., Svensson-Akusjarvi, S., Monteil, V., Vegvari, A., Benfeitas, R., Banerjea, A., Weber, F., Hewson, R.,Mirazimi, A., 2022. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target. Elife, 11, e76071.

  • Quirino-Teixeira, A.C., Andrade, F.B., Pinheiro, M.B.M., Rozini, S.V.,Hottz, E.D., 2022. Platelets in dengue infection: more than a numbers game. Platelets, 33, 176-183.

  • Ren, L., Du, S., Xu, W., Li, T., Wu, S., Jin, N.,Li, C., 2020. Current Progress on Host Antiviral Factor IFITMs. Front Immunol, 11, 543444.

  • Schoggins, J.W., Wilson, S.J., Panis, M., Murphy, M.Y., Jones, C.T., Bieniasz, P.,Rice, C.M., 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature, 472, 481-485.

  • Scholte, F.E.M., Zivcec, M., Dzimianski, J.V., Deaton, M.K., Spengler, J.R., Welch, S.R., Nichol, S.T., Pegan, S.D., Spiropoulou, C.F.,Bergeron, E., 2017. Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. Cell Rep, 20, 2396-2407.

  • Shtanko, O., Nikitina, R.A., Altuntas, C.Z., Chepurnov, A.A.,Davey, R.A., 2014. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog, 10, e1004390.

  • Simon, A.Y., Sutherland, M.R.,Pryzdial, E.L., 2015. Dengue virus binding and replication by platelets. Blood, 126, 378-385.

  • Tartour, K., Appourchaux, R., Gaillard, J., Nguyen, X.N., Durand, S., Turpin, J., Beaumont, E., Roch, E., Berger, G., Mahieux, R., Brand, D., Roingeard, P.,Cimarelli, A., 2014. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology, 11, 103.

  • Tignor, G.H.,Hanham, C.A., 1993. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res, 22, 309-325.

  • Tipih, T., Meade-White, K., Rao, D., Bushmaker, T., Lewis, M., Shaia, C., Feldmann, H.,Hawman, D.W., 2023. Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection. Antiviral Res, 218, 105703.

  • Xu, W., Wang, Y., Li, L., Qu, X., Liu, Q., Li, T., Wu, S., Liao, M., Jin, N., Du, S.,Li, C., 2022. Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA(2) subunit. Virol Sin, 37, 664-675.

  • Yao, L., Dong, H., Zhu, H., Nelson, D., Liu, C., Lambiase, L.,Li, X., 2011. Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line. J Viral Hepat, 18, e523-529.

  • Zani, A.,Yount, J.S., 2018. Antiviral Protection by IFITM3 In Vivo. Curr Clin Microbiol Rep, 5, 229-237.

  • Zhang, P., Ruan, C., Yang, G., Guan, Y., Zhu, Y., Li, Q., Dai, X., An, Y., Shi, X., Huang, P., Chen, Y., He, Z., Du, Z.,Liu, C., 2024. PGRN Inhibits Early B-cell Activation and IgE Production Through the IFITM3-STAT1 Signaling Pathway in Asthma. Adv Sci (Weinh), 11, e2403939.

  • Zhang, Y., Shen, S., Fang, Y., Liu, J., Su, Z., Liang, J., Zhang, Z., Wu, Q., Wang, C., Abudurexiti, A., Hu, Z., Zhang, Y.,Deng, F., 2018. Isolation, Characterization, and Phylogenetic Analysis of Two New Crimean-Congo Hemorrhagic Fever Virus Strains from the Northern Region of Xinjiang Province, China. Virol Sin, 33, 74-86.

  • Zivcec, M., Safronetz, D., Scott, D., Robertson, S., Ebihara, H.,Feldmann, H., 2013. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J Infect Dis, 207, 1909-1921.